177 related articles for article (PubMed ID: 18597411)
1. Relations between autoantibodies against oxidized low-density lipoprotein, inflammation, subclinical atherosclerosis, and cardiovascular disease in rheumatoid arthritis.
Peters MJ; van Halm VP; Nurmohamed MT; Damoiseaux J; Tervaert JW; Twisk JW; Dijkmans BA; Voskuyl AE
J Rheumatol; 2008 Aug; 35(8):1495-9. PubMed ID: 18597411
[TBL] [Abstract][Full Text] [Related]
2. Oxidized low-density lipoprotein autoantibodies, chronic infections, and carotid atherosclerosis in a population-based study.
Mayr M; Kiechl S; Tsimikas S; Miller E; Sheldon J; Willeit J; Witztum JL; Xu Q
J Am Coll Cardiol; 2006 Jun; 47(12):2436-43. PubMed ID: 16781371
[TBL] [Abstract][Full Text] [Related]
3. Autoantibodies against oxidized low-density lipoprotein (LDL) and carotid atherosclerosis in patients with rheumatoid arthritis.
Wada Y; Kuroda T; Murasawa A; Tanabe N; Nakano M; Gejyo F
Clin Exp Rheumatol; 2005; 23(4):482-6. PubMed ID: 16095116
[TBL] [Abstract][Full Text] [Related]
4. Activation of the immune system and inflammatory activity in relation to markers of atherothrombotic disease and atherosclerosis in rheumatoid arthritis.
Wållberg-Jonsson S; Cvetkovic JT; Sundqvist KG; Lefvert AK; Rantapää-Dahlqvist S
J Rheumatol; 2002 May; 29(5):875-82. PubMed ID: 12022343
[TBL] [Abstract][Full Text] [Related]
5. Autoantibodies against oxidized low density lipoproteins in patients with stable angina, unstable angina or peripheral vascular disease; pathophysiological implications.
Monaco C; Crea F; Niccoli G; Summaria F; Cianflone D; Bordone R; Bellomo G; Maseri A
Eur Heart J; 2001 Sep; 22(17):1572-7. PubMed ID: 11492986
[TBL] [Abstract][Full Text] [Related]
6. Proinflammatory high-density lipoprotein as a biomarker for atherosclerosis in patients with systemic lupus erythematosus and rheumatoid arthritis.
McMahon M; Grossman J; FitzGerald J; Dahlin-Lee E; Wallace DJ; Thong BY; Badsha H; Kalunian K; Charles C; Navab M; Fogelman AM; Hahn BH
Arthritis Rheum; 2006 Aug; 54(8):2541-9. PubMed ID: 16868975
[TBL] [Abstract][Full Text] [Related]
7. Effect of calcineurin inhibitors on low-density lipoprotein oxidation.
Cofan F; Cofan M; Campos B; Guerra R; Campistol JM; Oppenheimer F
Transplant Proc; 2005 Nov; 37(9):3791-3. PubMed ID: 16386540
[TBL] [Abstract][Full Text] [Related]
8. Antibodies to oxidized LDL and LDL-containing immune complexes as risk factors for coronary artery disease in diabetes mellitus.
Lopes-Virella MF; Virella G; Orchard TJ; Koskinen S; Evans RW; Becker DJ; Forrest KY
Clin Immunol; 1999 Feb; 90(2):165-72. PubMed ID: 10080827
[TBL] [Abstract][Full Text] [Related]
9. Oxidized low-density lipoprotein in plasma is a prognostic marker of subclinical atherosclerosis development in clinically healthy men.
Wallenfeldt K; Fagerberg B; Wikstrand J; Hulthe J
J Intern Med; 2004 Nov; 256(5):413-20. PubMed ID: 15485477
[TBL] [Abstract][Full Text] [Related]
10. The level of autoantibodies against oxidized LDL is not associated with the presence of coronary heart disease or diabetic kidney disease in patients with non-insulin-dependent diabetes mellitus.
Leinonen JS; Rantalaiho V; Laippala P; Wirta O; Pasternack A; Alho H; Jaakkola O; Ylä-Herttuala S; Koivula T; Lehtimäki T
Free Radic Res; 1998 Aug; 29(2):137-41. PubMed ID: 9790515
[TBL] [Abstract][Full Text] [Related]
11. Lipid peroxidation is enhanced in patients with systemic lupus erythematosus and is associated with arterial and renal disease manifestations.
Frostegård J; Svenungsson E; Wu R; Gunnarsson I; Lundberg IE; Klareskog L; Hörkkö S; Witztum JL
Arthritis Rheum; 2005 Jan; 52(1):192-200. PubMed ID: 15641060
[TBL] [Abstract][Full Text] [Related]
12. Traditional and nontraditional cardiovascular risk factors are associated with atherosclerosis in rheumatoid arthritis.
Dessein PH; Joffe BI; Veller MG; Stevens BA; Tobias M; Reddi K; Stanwix AE
J Rheumatol; 2005 Mar; 32(3):435-42. PubMed ID: 15742434
[TBL] [Abstract][Full Text] [Related]
13. Relation of myeloperoxidase promoter polymorphism and long-term hormone replacement therapy to oxidized low-density lipoprotein autoantibodies in postmenopausal women.
Mäkelä R; Dastidar P; Jokela H; Jaakkola O; Saarela M; Punnonen R; Lehtimäki T
Scand J Clin Lab Invest; 2006; 66(5):371-83. PubMed ID: 16901848
[TBL] [Abstract][Full Text] [Related]
14. Percutaneous coronary intervention results in acute increases in oxidized phospholipids and lipoprotein(a): short-term and long-term immunologic responses to oxidized low-density lipoprotein.
Tsimikas S; Lau HK; Han KR; Shortal B; Miller ER; Segev A; Curtiss LK; Witztum JL; Strauss BH
Circulation; 2004 Jun; 109(25):3164-70. PubMed ID: 15184281
[TBL] [Abstract][Full Text] [Related]
15. Autoantibodies against oxidized low-density lipoprotein and C-reactive protein are associated with diabetes and myocardial infarction in women.
Dotevall A; Hulthe J; Rosengren A; Wiklund O; Wilhelmsen L
Clin Sci (Lond); 2001 Nov; 101(5):523-31. PubMed ID: 11672458
[TBL] [Abstract][Full Text] [Related]
16. Oxidized low-density lipoprotein/beta2-glycoprotein I complexes and autoantibodies in patients with type 2 diabetes mellitus.
Lopez LR; Hurley BL; Simpson DF; Matsuura E
Ann N Y Acad Sci; 2005 Jun; 1051():97-103. PubMed ID: 16126948
[TBL] [Abstract][Full Text] [Related]
17. Impact of postprandial lipaemia on low-density lipoprotein (LDL) size and oxidized LDL in patients with coronary artery disease.
Granér M; Kahri J; Nakano T; Sarna SJ; Nieminen MS; Syvänne M; Taskinen MR
Eur J Clin Invest; 2006 Nov; 36(11):764-70. PubMed ID: 17032343
[TBL] [Abstract][Full Text] [Related]
18. Differences in human antioxidized LDL autoantibodies in patients with stable and unstable angina.
Fernandes JL; Orford JL; Garcia C; Coelho OR; Gidlund M; Blotta MH
J Autoimmun; 2004 Dec; 23(4):345-52. PubMed ID: 15571928
[TBL] [Abstract][Full Text] [Related]
19. Antibodies against human 60 kDa heat shock protein are not associated with cardiovascular disease in patients with rheumatoid arthritis.
van Halm VP; Slot MC; Nurmohamed MT; Tervaert JW; Dijkmans BA; Voskuyl AE
Ann Rheum Dis; 2006 May; 65(5):590-4. PubMed ID: 16249230
[TBL] [Abstract][Full Text] [Related]
20. [Ferritin, oxidative stress and coronary atherosclerosis].
Kraml P; Potocková J; Koprivová H; Stípek S; Crkovská J; Zima T; Andĕl M
Vnitr Lek; 2004 Mar; 50(3):197-202. PubMed ID: 15125369
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
